全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

边缘性角膜溃疡的研究现状
Research Status of Marginal CornealUlcer

DOI: 10.12677/HJO.2023.121005, PP. 31-37

Keywords: 边缘性角膜溃疡,自身免疫性疾病,治疗
Peripheral Ulcerative Keratitis
, Autoimmune Disease, Treatment

Full-Text   Cite this paper   Add to My Lib

Abstract:

边缘性角膜溃疡(Peripheral Ulcerative Keratitis, PUK)是一种主要发生在角膜边缘的新月型的炎症性疾病,主要表现为角膜上皮缺损和角膜基质破坏;主要与自身免疫及边缘角膜的特殊解剖部位及生理学特征及环境等因素有关。PUK可能是局部或全身的感染及非感染性病因所致。本综述总结了与非感染性PUK相关的临床特征、发病机制和疾病,以及近期开发的治疗方案。
Peripheral ulcerative keratitis (PUK) is a crescent-shaped inflammatory disease that mainly occurs in the corneal margin, and its manifestations are corneal epithelial defect and corneal stromal destruction. It is mainly related to autoimmunity, special anatomical and physiological features of marginal cornea and environmental factors. PUK may be due to local or systemic infection and non-infectious etiology. This review summarizes the clinical features, pathogenesis, and disease associated with non-infectious PUK, as well as recently developed treatment options.

References

[1]  McKibbin, M., Isaacs, J.D. and Morrell, A.J. (1999) Incidence of Corneal Melting in Association with Systemic Disease in the Yorkshire Region, 1995-7. British Journal of Ophthalmology, 83, 941-943.
https://doi.org/10.1136/bjo.83.8.941
[2]  Odorcic, S., Keystone, E.C. and Ma, J.J.K. (2009) Infliximab for the Treatment of Refractory Progressive Sterile Peripheral Ulcerative Keratitis Associated with Late Corneal Perforation: 3-Year Follow-Up. Cornea, 28, 89-92.
https://doi.org/10.1097/ICO.0b013e318181a84f
[3]  Ladas, J.G. and Mondino, B.J. (2000) Systemic Disorders Associated with Peripheral Corneal Ulceration. Current Opinion in Ophthalmology, 11, 468-471.
https://doi.org/10.1097/00055735-200012000-00014
[4]  Akpek, E.K., Thorne, J.E., Qazi, F.A., et al. (2004) Evaluation of PATIENTS with Scleritis for Systemic Disease. Ophthalmology, 111, 501-506.
https://doi.org/10.1016/j.ophtha.2003.06.006
[5]  Tauber, J., Sainz, D.L.M., Hoang-Xuan, T., et al. (1990) An Analysis of Therapeutic Decision Making Regarding Immunosuppressive Chemotherapy for Peripheral Ulcerative Keratitis. Cornea, 9, 66-73.
https://doi.org/10.1097/00003226-199001000-00013
[6]  Messmer, E.M. and Foster, C.S. (1999) Vasculitic Peripheral Ulcerative Keratitis. Survey of Ophthalmology, 43, 379-396.
https://doi.org/10.1016/S0039-6257(98)00051-4
[7]  Foster, C.S., Forstot, S.L. and Wilson, L.A. (1984) Mortality Rate in Rheumatoid Arthritis Patients Developing Necrotizing Scleritis or Peripheral Ulcerative Keratitis. Effects of Systemic Immunosuppression. Ophthalmology, 91, 1253-1263.
https://doi.org/10.1016/S0161-6420(84)34160-4
[8]  Gupta, Y., Kishore, A., Kumari, P., et al. (2021) Peripheral Ulcerative Keratitis. Survey of Ophthalmology, 66, 977-998.
https://doi.org/10.1016/j.survophthal.2021.02.013
[9]  Gonzalez, G., Sasamoto, Y., Ksander, B.R., et al. (2017) Limbal Stem Cells: Identity, Developmental Origin, and Therapeutic Potential. Wiley Interdisciplinary Reviews: Developmental Biology, 7, e303.
https://doi.org/10.1002/wdev.303
[10]  Robin, J.B., Schanzlin, D.J., Verity, S.M., et al. (1986) Peripheral Corneal Disorders. Survey of Ophthalmology, 31, 1-36.
https://doi.org/10.1016/0039-6257(86)90049-4
[11]  Marsovszky, L., Resch, M.D., Németh, J., Toldi, G., et al. (2013) In Vivo Confocal Microscopic Evaluation of Corneal Langerhans Cell Density, and Distribution and Evaluation of Dry Eye in Rheumatoid Arthritis. Innate Immunity, 19, 348-354.
https://doi.org/10.1177/1753425912461677
[12]  Messmer, E.M. and Foster, C.S. (1995) Destructive Corneal and Scleral Disease Associated with Rheumatoid Arthritis. Medical and Surgical Management. Cornea, 14, 408-417.
https://doi.org/10.1097/00003226-199507000-00010
[13]  Müller, L.J., Pels, E., Schurmans, L., et al. (2004) A New Three-Dimensional Model of the Organization of Proteoglycans and Collagen Fibrils in the Human Corneal Stroma. Experimental Eye Research, 78, 493-501.
https://doi.org/10.1016/S0014-4835(03)00206-9
[14]  Müller, L.J., Vrensen, G.F., Pels, L., et al. (1997) Architecture of Human Corneal Nerves. Investigative Ophthalmology & Visual Science, 38, 985-994.
[15]  Dana, M.R., Qian, Y. and Hamrah, P. (2000) Twenty-Five-Year Panorama of Corneal Immunology: Emerging Concepts in the Immunopathogenesis of Microbial Keratitis, Peripheral Ulcerative Keratitis, and Corneal Transplant Rejection. Cornea, 19, 625.
https://doi.org/10.1097/00003226-200009000-00008
[16]  Foster, C.S., Kenyon, K.R., Greiner, J., et al. (1979) The Immunopathology of Mooren’s Ulcer. American Journal of Ophthalmology, 88, 149-159.
https://doi.org/10.1016/0002-9394(79)90459-8
[17]  Mondino, B.J., Brown, S.I. and Rabin, B.S. (1978) Cellular Immunity in Mooren’s Ulcer. American Journal of Ophthalmology, 85, 788-791.
https://doi.org/10.1016/S0002-9394(14)78106-1
[18]  Mondino, B.J. (1988) Inflammatory Diseases of the Peripheral Cornea. Ophthalmology, 95, 463-472.
https://doi.org/10.1016/S0161-6420(88)33164-7
[19]  Keenan, J.D., Mandel, M.R. and Margolis, T.P. (2011) Peripheral Ulcerative Keratitis Associated with Vasculitis Manifesting Asymmetrically as Fuchs Superficial Marginal Keratitis and Terrien Marginal Degeneration. Cornea, 30, 825.
https://doi.org/10.1097/ICO.0b013e3182000c94
[20]  Gregory, J.K. and Foster, C.S. (1996) Peripheral Ulcerative Keratitis in the Collagen Vascular Diseases. International Ophthalmology Clinics, 36, 21-30.
https://doi.org/10.1097/00004397-199603610-00005
[21]  Fernandes, S.R.M., Singsen, B.H. and Hoffman, G.S. (2000) Sarcoidosis and Systemic Vasculitis. Seminars in Arthritis & Rheumatism, 30, 33-46.
https://doi.org/10.1053/sarh.2000.8364
[22]  Riley, G.P., Harrall, R.L., Watson, P.G., et al. (1995) Collagenase (MMP-1) and TIMP-1 in Destructive Corneal Disease Associated with Rheumatoid Arthritis. Eye, 9, 703.
https://doi.org/10.1038/eye.1995.182
[23]  Perry, H.D. and Golub, L.M. (1986) Systemic Tetracyclines in the Treatment of Noninfected Corneal Ulcers: A Case Report and Proposed New Mechanism of Action. Annals of Ophthalmology, 17, 742-744.
[24]  Ralph, R.A. (2000) Tetracyclines and the Treatment of Corneal Stromal Ulceration. Cornea, 19, 274-277.
https://doi.org/10.1097/00003226-200005000-00003
[25]  Ka?maz, R.O., Kempen, J.H., Newcomb, C., et al. (2010) Cyclosporine for Ocular Inflammatory Diseases. Ophthalmology, 117, 576-584.
https://doi.org/10.1016/j.ophtha.2009.08.010
[26]  Golub, L.M. (1991) Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs. Critical Reviews in Oral Biology and Medicine: An Official Publication of the American Association of Oral Biologists, 2, 297-321.
https://doi.org/10.1177/10454411910020030201
[27]  Galor, A. and Thorne, J.E. (2007) Scleritis and Peripheral Ulcerative Keratitis. Rheumatic Disease Clinics of North America, 33, 835-854.
https://doi.org/10.1016/j.rdc.2007.08.002
[28]  Jabs, D.A., Rosenbaum, J.T., Foster, C.S., et al. (2000) Guidelines for the Use of Immunosuppressive Drugs in Patients with Ocular Inflammatory Disorders: Recommendations of an Expert Panel. American Journal of Ophthalmology, 130, 492-513.
https://doi.org/10.1016/S0002-9394(00)00659-0
[29]  Sainz de la Maza, M., Foster, C.S., Jabbur, N.S. and Baltatzis, S. (2002) Ocular Characteristics and Disease Associations in Scleritis-Associated Peripheral Keratopathy. Archives of Ophthalmology, 120, 15-19.
https://doi.org/10.1001/archopht.120.1.15
[30]  Squirrell, D.M., Winfield, J. and Amos, R.S. (1999) Peripheral Ulcerative Keratitis “Corneal Melt” and Rheumatoid Arthritis: A Case Series. Rheumatology, 38, 1245-1248.
https://doi.org/10.1093/rheumatology/38.12.1245
[31]  Messmer, E.M. and Foster, C.S. (1999) Vasculitic Peripheral Ulcerative Keratitis. Survey of Ophthalmology, 43, 379-396.
https://doi.org/10.1016/S0039-6257(98)00051-4
[32]  Sato, T., Minakuchi, S., Mochizuki, M. and Takeuchi, M. (2014) Acute Anterior Uveitis after Discontinuation of Tocilizumab in a Patient with Rheumatoid Arthritis. Clinical Ophthalmology, 8, 187-190.
https://doi.org/10.2147/OPTH.S54929
[33]  Stylianides, A., Jones, M.N., Stewart, R.M., et al. (2013) Rheumatoid Arthritis-Associated Corneal Ulceration: Mortality and Graft Survival. Ophthalmology, 120, 682-686.
https://doi.org/10.1016/j.ophtha.2012.09.050
[34]  Galor, A., Jabs, D.A., Leder, H.A., et al. (2008) Comparison of Antimetabolite Drugs as Corticosteroid-Sparing Therapy for Noninfectious Ocular Inflammation. Ophthalmology, 115, 1826-1832.
https://doi.org/10.1016/j.ophtha.2008.04.026
[35]  Mccarthy, J.M., Dubord, P.J., Chalmers, A., et al. (1992) Cyclosporine A for the Treatment of Necrotizing Scleritis and Corneal Melting in Patients with Rheumatoid Arthritis. Journal of Rheumatology, 19, 1358-1361.
[36]  Thomas, J.W. and Pflugfelder, S.C. (2005) Therapy of Progressive Rheumatoid Arthritis-Associated Corneal Ulceration with Infliximab. Cornea, 24, 742.
https://doi.org/10.1097/01.ico.0000154391.28254.1d
[37]  Antao, S.F., Ayoub, T., Tahir, H., et al. (2012) Stabilization of Bilateral Progressive Rheumatoid Corneal Melt with Infliximab. Case Reports in Ophthalmological Medicine, 2012, Article ID: 173793.
https://doi.org/10.1155/2012/173793
[38]  Atchia, I.I., Kidd, C.E. and Bell, R.W.D. (2006) Rheumatoid Arthritis-Associated Necrotizing Scleritis and Peripheral Ulcerative Keratitis Treated Successfully with Infliximab. Journal of Clinical Rheumatology Practical Reports on Rheumatic & Musculoskeletal Diseases, 12, 291-293.
https://doi.org/10.1097/01.rhu.0000249766.24780.95
[39]  Kawabata, Y., Miyaji, Y., Nakano, T., et al. (2012) A Change in Treatment from Etanercept to Infliximab Was Effective to Control Scleritis in a Patient with Rheumatoid Arthritis. Acta Ophthalmologica, 90, e161-e162.
https://doi.org/10.1111/j.1755-3768.2010.02090.x
[40]  Ashok, D., Ayliffe, W.H. and Kiely, P. (2005) Necrotizing Scleritis Associated with Rheumatoid Arthritis: Long-Term Remission with High-Dose Infliximab Therapy. Rheumatology, 44, 950-951.
https://doi.org/10.1093/rheumatology/keh635
[41]  Smith, J.R., Levinson, R., Holland, G.N., et al. (2001) Differential Efficacy of Tumor Necrosis Factor Inhibition in the Management of Inflammatory Eye Disease and Associated Rheumatic Disease. Arthritis & Rheumatology, 45, 252-257.
https://doi.org/10.1002/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5
[42]  García, C.C., Rosso, M.L., Bertoni, M.D., et al. (2017) Necrotising Scleritis and Peripheral Ulcerative Keratitis Associated with Rheumatoid Arthritis Treated with Rituximab. KlinischeMonatsbl?tter für Augenheilkunde, 234, 567-570.
https://doi.org/10.1055/s-0042-121315
[43]  Freidlin, J., Wong, I.G. and Acharya, N. (2007) Rituximab Treatment for Peripheral Ulcerative Keratitis Associated with Wegener’s Granulomatosis. British Journal of Ophthalmology, 91, 1414.
https://doi.org/10.1136/bjo.2006.113316
[44]  Feder, R.S. and Krachmer, J.H. (1984) Conjunctival Resection for the Treatment of the Rheumatoid Corneal Ulceration. Ophthalmology, 91, 111-115.
https://doi.org/10.1016/S0161-6420(84)34319-6
[45]  Vera, L., Benzerroug, M., Gueudry, J., et al. (2009) Mise au point sur l’utilisation des colles tissulaires en ophtalmologie. Journal Fran?ais d’Ophtalmologie, 32, 290-305.
https://doi.org/10.1016/j.jfo.2009.01.008
[46]  Maeno, A., Naor, J., Lee, H.M., Hunter, W.S. and Rootman, D.S. (2000) Three Decades of Corneal Transplantation: Indications and Patient Characteristics. Cornea, 19, 7-11.
https://doi.org/10.1097/00003226-200001000-00002
[47]  Artifoni, M., et al. (2014) Ocular Inflammatory Diseases Associated with Rheumatoid Arthritis. Nature Reviews Rheumatology, 10, 108-116.
https://doi.org/10.1038/nrrheum.2013.185

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133